ABSTRACT Protease-nexin (PN), a component released by normal human fibroblasts into culture medium, forms covalent linkages with thrombin (Th) and the urinary plasminogen activator urokinase, apparently with their catalytic site serines. The present studies explored the function of PN by examining the interaction of protease-PN complexes with human fibroblasts and the consequences of this interaction. Th-PN and urokinase-PN complexes bind to cells via the PN portion of the complexes. The binding is selectively inhibited by heparin. Because PN has a heparin-binding site, this indicates that protease-PN complexes might bind to a cellular heparin-like site. After binding, the complexes are internalized. By inhibiting endocytosis with phenylarsine oxide, which does not affect cellular binding of Th-PN complexes, we showed that complexes must be internalized before they are degraded. Kinetic analysis of internalization and degradation of Th-PN showed that complexes are internalized more rapidly than they dissociate from the cell surface; by 120 min of incubation at 37°C most cell-bound Th-PN complexes are degraded to amino acids. The results are summarized in a model showing how PN mediates the cellular binding, internalization, and degradation of serine proteases through formation of protease-PN complexes. This series of events may be involved in the regulation of serine protease activity at the cell surface and in the extracellular environment.
Recently we identified protease-nexin (PN), a component released from normal human foreskin (HF) cells that combines with serine proteases, including thrombin (Th) and urokinase (1) . PN (3) . Urokinase (low molecular weight form, 35 kilodaltons) was a gift from Collaborative Research (Waltham, MA) . Heparin from porcine intestinal mucosa, soybean trypsin inhibitor (SBTI), and phenylarsine oxide (PhAsO) were products of Sigma. Na'"I was obtained from Amersham, chloroglycouril from Pierce, and silica gel 60 aluminum sheets from Merck. We purchased Dulbecco-Vogt modified Eagle's medium (DV medium) from Flow Laboratories (Rockville, MD); trypsin solution, glutamine, and antibiotics from GIBCO; and calf serum from Irvine Scientific (Santa Ana, CA).
Cell Cultures, Gel Electrophoresis, and Radioiodination. HF fibroblast-like cells (passage 6-16) were cultured as described (4) . Conditioned medium was obtained from confluent HF cultures that had been in serum-free DV medium for 48 hr. NaDodSOpolyacrylamide gel electrophoresis was carried out as described (1) except that the sample buffer was 2 mM EDTA/ 7 mM dithiothreitol/1% NaDodSOJ20 mM [bis(2-hydroxyethyl)-amino] tris(hydroxymethyl)methane, pH 7.5. This modification resulted in less breakdown of protease-PN complexes during electrophoresis. Mono['251]iodotyrosine ("2I-Tyr) and 125I-were separated as follows: Equal parts of culture medium and 2-fold concentrated electrophoresis sample buffer were mixed and heated at 100°C for 5 min. Mixtures (1 ml) were applied to NaDodSOJpolyacrylamide gels consisting ofa 2.5-cm 4% stacking gel and a 10-cm 10% separating gel. 125I-Tyr migrated directly behind bromophenol blue and 12'I-migrated with phenol red. 12'I-Tyr and 125I-were identified by applying extracts ofgel slices (in acetone/acetic acid, 3:2 vol/vol) to silica gel 60 aluminum strips using a 1-butanoVacetic acid/water (10:1:1, vol/vol) developing solvent (5) . Standards (prepared with Na'25I, chloramine-T, and tyrosine) were also applied.
Radioiodination of Th and urokinase by using chloroglycouril (6) was performed as described (1 1. Binding of protease-PN complexes to HF and mouse embryo cells. (A) 125I-Th (500 ng/ml) was incubated for 30 min at 370C with either fresh serum-free DV medium or serum-free DV medium that had been conditioned by HF cells. Samples of each then received heparin, Th, or no addition as indicated below. These samples were further incubated with HF cell cultures that had been rinsed with DV medium. After 30 min at 370C, samples were prepared for NaDodSO4/ polyacrylamide gel electrophoresis. Incubation with conditioned medium, lanes 1-3; incubation with fresh DV medium, lanes 4-6. Lanes 1 and 4, no addition; lanes 2 and 5, heparin addition (30 ng/ml); lanes 3 and 6, Th addition (10 pg/ml). (B) 125I-Th (500 ng/ml) was incubated for 30 min at 370C with either serum-free DV medium or serum-free DV medium that was conditioned by mouse embryo cells. Each mixture was then further incubated with mouse embryo cell cultures that had been rinsed with serum-free DV. After 30 min at 370C, samples were prepared for NaDodSO4/polyacrylamide gel electrophoresis. Incubation with fresh DV medium, lane 1; incubation with conditioned medium, lane 2. (C) 1251-urokinase (UK) (500 ng/ml) was incubated for 30 min at 370C with conditioned medium. After addition of nonlabeled urokinase (10 tg/ml), one sample received heparin (30 ,ug/ml). Both mixtures were then further incubated with HF cell cultures that had been rinsed with serum-free DV medium. After 30 min at 37°C, samples were prepared for NaDodSO4/polyacrylamide gel electrophoresis. Incubation without heparin, lane 1; incubation with heparin, lane 2. (Fig. 1C) . These results show that 125I-protease-PN complexes bound to the cells and that they bound via the PN moiety. Previously we showed that PN has a high-affinity heparinbinding site and that heparin greatly increases the rate oflinking between Th and PN released from the cells (1). To determine if heparin also affected cellular binding of 1251-Th-PN, we incubated 125I-Th-PN complexes, preformed in conditioned medium, with cells in the presence or absence of heparin (30 jig/ ml). Heparin greatly decreased the appearance of cell-bound 125I-Th-PN at 37°C (Fig. 1A) or 0°C (arrowhead, Figs. 2 and 3) . Heparin also markedly inhibited the binding of 1251-urokinase-PN complexes to cells (Fig. 1C) . It is unlikely that interaction of heparin with the protease caused this effect; although Th has a heparin-binding site, urokinase does not, judged by their ability to bind to heparin-derivatized Sepharose beads (unpublished results). This effect ofheparin did not reflect a nonspecific inhibitory effect of polyanions on the binding of polypeptides to cells. Heparin at even 300 ,tg/ml did not detectably affect binding of 1251-labeled epidermal growth factor to HF cells Although the association of 1251-protease-PN complexes with HF cells was heparin sensitive, after 125I-Th-PN complexes became associated with the cell surface neither heparin nor a variety of other agents displaced them when incubations were carried out at 4°C. Table 2 shows that the complexes were not displaced by heparin at 30 kug/ml or extracted with 1 mM EDTA or 0.5 M urea, conditions that remove many peripheral membrane proteins (8) . KC1 at 3 M, an agent that extracts a portion of the membrane-bound HL-A histocompatibility antigen (9) ofthe complexes by the cells during the 16-hr incubation at 4°C. Over 90% of these complexes were removed by a brief trypsin treatment after the 16-hr incubation, indicating that they were still present at the cell surface. These results demonstrated that 125I-Th-PN complexes became bound to the cell surface with a high affinity, and, by the criteria used, behaved as integral components of the membrane.
We previously reported that a number of cell types, such as mouse embrvo cells and Chinese hamster lung cells, linked 1251_ Th to cell surface components that were similar in size to HF cell PN (10) . However, most cell types formed substantially fewer complexes than HF cells do. These studies were carried out by incubating the cells with 1251-Th in fresh medium. In view of the ability of 125I-Th-PN complexes to form in conditioned medium and bind to cells, we examined the amount of '251-Th-PN that became associated with mouse embryo and Chinese hamster lung cells when the '"I-Th was added to cultures containing their respective conditioned serum-free medium. Under this condition, 3-to 4-fold more 125I-Th-PN complexes became associated with mouse embryo cells (Fig. 1B) (Table 1) . Thus, preformed '"I-Th-PN complexes were incubated with cells in the presence ofhirudin at 0°C for 3 hr (Fig. 2) . After this incubation all cell-bound '"I-Th-PN was present at the cell surface as evidenced by its complete sensitivity to a brief trypsin treatment.
These cells were then placed in medium without 125I-Th-PN and were shifted to 37°C; the presence of intra-cellular and surface-bound '"I-Th-PN was determined by treating the cells with trypsin. The results presented in Fig. 2 show that there was a rapid and progressive loss ofcell surface '25I-Th-PN. This loss of cell surface complexes could have been caused by extracellular destruction or dissociation of the complexes, by internalization ofcomplexes, or by both processes. To measure these two processes some cell cultures were treated with PhAsO, a potent inhibitor of endocytosis in oocytes (7) . PhAsO hibited endocytosis of 1251-Th-PN at 37°C (Fig. 2) . However, it did not affect cellular binding of '251-Th-PN at 0°C (Fig. 2 Inset), indicating that dissociation of '25I-Th-PN from the cell surface at 0°C was not detectably altered by PhAsO. After 5 min of incubation at 37°C, PhAsO-treated cultures lost about twice as much Th-PN from their cell surface as untreated cultures did (Fig. 2) . Additionally, the amount ofTh-PN internalized during the 5-10 min incubation was similar to the amount of Th-PN lost from the cell surface after 5 min in untreated cultures. These results indicated that internalization of complexes was more rapid than dissociation of complexes, because virtually all Th-PN was cell associated after untreated cultures were incubated for 5 min, whereas there was a significant loss of Th-PN from PhAsO-treated cultures after 5 min. Approximately one-sixth oftotal cellular 125I-Th-PN became insensitive to trypsin during the 5-10 min incubation at 37°C (Fig. 2) . However, a comparison of amounts of surface-bound and intracellular '25I-Th-PN at 30-min and later time points showed that only a small fraction of the lmI-Th-PN removed from the cell surface was recovered in the trypsin-insensitive (intracellular) fraction. These results
2342
Cell Biology: Low et al.
Proc. Natl. Acad. Sci. USA 78 (1981) 2343 indicated that I251-Th-PN not only was rapidly internalized but also was rapidly degraded.
Degradation of 1251-Th-PN. To determine the kinetics of cellular degradation of 125I-Th-PN, preformed '25I-Th-PN complexes were bound to the cell surface at 00C and cells were then shifted to 370C as described above for Fig. 2 . At various times, medium was assayed for the presence of '25I-Tyr and 1251-. The results presented in Fig. 3 showed that 125I-was released into the medium. This 1251-was probably not derived from cellbound 125I-Th-PN or I251-Th, because I25-levels did not change with increasing incubation times. Additionally, similar amounts of 25I-were released from PhAsO-treated and untreated cells, indicating that internalization was not required for 25I-release. Because about 10% of the total 125I radioactivity in the binding medium was in the form of 1251-, it seems likely that some 125i-in this mixture became associated with cells or dishes at 00C, but rapidly dissociated at 37TC.
Measurement of 1251-Tyr released into the medium indicated that at least the Th portion of I251-Th-PN was rapidly degraded to free amino acids by cells. After 10 min of incubation at 370C there was no detectable "25I-Tyr release (Fig. 3A) . However, after 30 min of incubation, 1251-Tyr release from cells was detectable, and further release occurred by 120 min of incubation ( Fig. 3 B and C) . Importantly, PhAsO-treated cells did not release "25I-Tyr into the medium even after 120 min of incubation (Fig. 3C) . Thus, 1251-Th-PN complexes must be internalized before they are degraded to amino acids.
The results presented in Fig. 3E show that, by 120 min of could have been generated from unlinked "25I-Th that bound to cells at 0°C in the presence of hirudin, and was thus nonspecifically bound (Fig. 3E) . To determine what proportion of 125I-Tyr was generated from free '251-Th, 125I-Th-PN complexes were incubated with cells at 0°C in the presence of heparin. Under these conditions, only a small fraction of '25I-Th-PN (8% of the control culture that did not receive heparin) was cell bound after 3 hr (arrowhead, Fig. 3E ), whereas about 42% of the '25I-Th remained cell bound (data not shown). Fig. 3D shows that under these conditions 125I-Tyr was not generated after 30 min of incubation. However, after 120 min of incubation, cells released a small amount of 125I-Tyr. Degradation of 125I-Th at 120 min but not at earlier times was supported by cellular binding results (Fig. 3E) . Thus, in Fig. 3E about 8000 cpm of the 1251-Tyr generated after 120-min incubation was probably due to degradation of nonspecifically bound '25I-Th.
Together these results showed not only that '25I-Th-PN must be internalized before degradation to amino acids but also that degradation was rapid. Over 40% of the "25I-Tyr resulting from degradation of '25I-Th-PN was generated after only 30 min of incubation. Importantly, Fig. 3E shows that after 120 min of incubation most cell-bound I251-Th-PN had been degraded, as evidenced by the production of "25I-Tyr. This result supports our interpretation, presented above, that internalization ofTh-PN is more rapid than dissociation ofTh-PN, because we have also shown that degradation of complexes cannot occur unless they are internalized.
Possible Functions of PN. In this paper we describe a series of events that occur upon release of PN from HF cells. Our results, summarized in Fig. 4 , show that released PN (step 1) forms a linkage (step 2) with serine proteases (Th and urokinase) (10 ,ug/ml) for 3 hr; the cultures were then shifted to 3700 as described for Fig. 2 . Additionally, some cultures received heparin (300 ,g/ml). After various times, medium was processed for NaDodSO4/polyacrylamide gel electrophoresis and iodinated compounds were separated and identified by thin-layer chromatography. Positions Fig. 4 and also by direct inhibition ofproteases by PN. Our studies with urokinase indicate that this plasminogen activator loses its fibrinolytic activity when linked to PN (11) . The presence of binding sites for PN at the cell surface could play the important role of increasing the concentration of PN at this critical location. For example, at this site PN could directly modulate thrombin-stimulated cell division, because proteolysis by thrombin at the cell surface is sufficient to produce a proliferative response (12, 13) . PN may be identical to a recently described mouse cytosol protein called trypsin combining protein (14) . Finally, it is noteworthy that a2-macroglobulin, a serum protease inhibitor, forms complexes with proteases and mediates their binding, internalization, and degradation. However, a2 macroglobulin does not form a covalent linkage to the catalytic site of the protease (15) and it is supplied by plasma or serum rather than the cells that bind and internalize the complexes (16, 18) . Because PN is made by the same cells that bind, internalize, and degrade protease-PN complexes, it could provide a mechanism for autoregulation by these cells of serine protease levels at their cell surface.
